HOW TO TREAT VTEC IN CANCER PATIENTS IN THE ACUTE PERIOD? EXTENDED TREATMENT. THE ROLE OF DIRECT ORAL ANTICOAGULANTS. THE RESULTS OF HOKUSAI VTE CANCER STUDY
Cancer is one of the most significant risk factors for venous thromboembolic complications (VTEC). The article discusses the features of the treatment of cancer patients with VTEC. The issues of alternative anticoagulant therapy are considered. The article presents the results of HOKUSAI VTE Cancer...
Saved in:
Main Author: | Yulia A. Fedotkina (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extended anticoagulation for VTE: what evidence justifies it?
by: Anushka Walia, et al.
Published: (2023) -
Comparison Analysis Performance Of Honda Jazz Using Active VTec System And Non-Active VTec System Engine
by: Sanjaya, Dhanil
Published: (2012) -
Comparison Analysis Of Engine Performance Using I-Vtec System And Engine Without I-Vtec System Honda Cr-V
by: SUHARDI, JONAS, et al.
Published: (2014) -
Challenges in Management of VTE in Children With Cancer: Risk Factors and Treatment Options
by: Nasrin Samji, et al.
Published: (2022) -
Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning
by: Samir Khan Townsley, et al.
Published: (2023)